FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness.
Canepa E, Parodi-Rullan R, Vazquez-Torres R, Gamallo-Lana B, Guzman-Hernandez R, Lemon NL, Angiulli F, Debure L, Ilies MA, Østergaard L, Wisniewski T, Gutiérrez-Jiménez E, Mar AC, Fossati S.
Canepa E, et al. Among authors: vazquez torres r.
Alzheimers Dement. 2023 Nov;19(11):5048-5073. doi: 10.1002/alz.13063. Epub 2023 Apr 26.
Alzheimers Dement. 2023.
PMID: 37186121
Free PMC article.